0001615219-16-000105.txt : 20160125 0001615219-16-000105.hdr.sgml : 20160125 20160125115107 ACCESSION NUMBER: 0001615219-16-000105 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160121 FILED AS OF DATE: 20160125 DATE AS OF CHANGE: 20160125 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Flex Pharma, Inc. CENTRAL INDEX KEY: 0001615219 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 465087339 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 800 BOYLSTON STREET STREET 2: 24TH FLOOR CITY: BOSTON STATE: MA ZIP: 02199 BUSINESS PHONE: 617-874-1821 MAIL ADDRESS: STREET 1: 800 BOYLSTON STREET STREET 2: 24TH FLOOR CITY: BOSTON STATE: MA ZIP: 02199 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: McCabe John P. CENTRAL INDEX KEY: 0001630720 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36812 FILM NUMBER: 161357920 MAIL ADDRESS: STREET 1: C/O FLEX PHARMA, INC. STREET 2: 800 BOYLSTON STREET CITY: BOSTON STATE: MA ZIP: 02199 4 1 wf-form4_145374065637537.xml FORM 4 X0306 4 2016-01-21 0 0001615219 Flex Pharma, Inc. FLKS 0001630720 McCabe John P. C/O FLEX PHARMA, INC. 800 BOYLSTON STREET BOSTON MA 02199 0 1 0 0 VP of Finance & Treasurer Stock Option (right to buy) 9.59 2016-01-21 4 A 0 40000 0 A 2026-01-21 Common Stock 40000.0 40000 D 25% of the total shares underlying this option vest on January 21, 2017 and the remaining shares vest 1/48 per month over the next 36 months thereafter, subject to continued service to the Issuer through each vesting date. /s/ Robert Hadfield, Attorney-in-Fact 2016-01-22